Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2261968 | chr13:114153181 | T/C | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2265140 | chr13:114175358 | T/C | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2265141 | chr13:114175387 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2265142 | chr13:114177518 | T/G | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265143 | chr13:114177558 | T/G | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265145 | chr13:114177851 | A/G | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265147 | chr13:114179704 | G/A | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265148 | chr13:114180787 | T/C | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2265149 | chr13:114159397 | G/A | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2265150 | chr13:114159308 | C/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2265151 | chr13:114158976 | C/T | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2265154 | chr13:114153471 | G/T | 4.5E-12 | 177 | 24.17 | 29.57 | 3.32 | KM Plot |
PCPG | rs2265788 | chr13:114153348 | A/G | 0.000416 | 176 | 24.23 | 28.95 | 3.7 | KM Plot |
PCPG | rs2265789 | chr13:114159124 | A/C | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2265790 | chr13:114159404 | A/G | 3.85E-12 | 178 | 24.23 | 29.57 | 3.32 | KM Plot |